A recent study published in Hypertension highlights a concerning trend regarding chronic hypertension in pregnant women in the United States.
Between 2008 and 2021, the prevalence of this condition has doubled from 1.8% to 3.7%. Despite this significant increase, the percentage of women receiving oral antihypertensive medications remained relatively stable, fluctuating between 57% and 60%
This indicates that nearly 40% of pregnant women with chronic hypertension did not receive medication to manage their condition.
The study also noted a shift in the types of medications used to treat chronic hypertension during pregnancy [1]. The use of labetalol increased from 19% to 42% and nifedipine usage rose from 9% to 17%.
On the other hand, the use of methyldopa and hydrochlorothiazide saw a significant decline. These changes in medication preferences reflect evolving medical practices and potential improvements in treatment efficacy and safety for pregnant women.
Treating chronic hypertension during pregnancy is crucial, as it can significantly reduce the risk of adverse outcomes for both the mother and the baby [2]. However, the introduction of the 2017 American College of Cardiology and American Heart Association guidelines for hypertension did not lead to significant changes in the prevalence or treatment patterns of chronic hypertension among pregnant women.
This comprehensive analysis illustrates the treatment gaps in managing chronic hypertension during pregnancy. The findings call attention to the need for improved healthcare strategies to address this condition better and safeguard maternal and fetal health.
Ensuring that more pregnant women receive appropriate treatment for chronic hypertension is essential for reducing health risks and improving outcomes [3].
The study highlights the importance of ongoing research and adaptation in medical practices to effectively manage chronic hypertension in pregnant women, ultimately aiming for better health outcomes for both mothers and their babies.
[1] https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.124.22731
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617800/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289217/
